LECAP Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,750
Closed -$766K 357
2025
Q4
$766K Buy
+30,750
New +$775K 0.3% 128
2025
Q3
Sell
-22,806
Closed -$553K 369
2025
Q2
$553K Sell
22,806
-58,387
-72% -$1.36M 0.2% 192
2025
Q1
$2.06M Buy
81,193
+14,050
+21% +$368K 0.48% 79
2024
Q4
$1.78M Sell
67,143
-12,439
-16% -$337K 0.48% 81
2024
Q3
$2.3M Buy
+79,582
New +$2.32M 0.5% 69
2024
Q1
Sell
-45,970
Closed -$1.32M 360
2023
Q4
$1.32M Buy
+45,970
New +$1.39M 0.48% 69

Other funds holding PFE

LECAP Asset Management's PFE Position: Q1 2026 in Review

LECAP Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 30,750 shares — an estimated $766K sold.

LECAP Asset Management first reported a position in PFE in Q4 2023 and held it in 6 quarters. The position peaked at $2.3M in Q3 2024. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • LECAP Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • LECAP Asset Management sold 30,750 Pfizer shares in Q1 2026, an estimated $766K.
  • LECAP Asset Management first reported a position in Pfizer in Q4 2023 and held it in 6 quarters.
  • LECAP Asset Management's Pfizer position peaked at $2.3M in Q3 2024.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on LECAP Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.